Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 826

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 826
---
 gross unrealized losses of the Company’s available-for-sale marketable securities by investment category and disaggregated by the length of time that individual debt securities have been in a continuous unrealized loss position as of December 31, 2023 and 2022:

F-55

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(amounts in thousands, except share and per share data) As of December 31, 2023

| ​                                  
 ​                                  | ​ 
 ​ | ​ 
 ​ | Less than 12 Months 
 FairValue           |   |   |   | ​ | ​ | GrossUnrealizedLosses |   |   |   | ​ 
 ​ | ​ 
 ​ | 12 Months or Greater 
 FairValue            |   |       |   | ​ | ​ | GrossUnrealizedLosses |   |      |   | ​ 
 ​ | ​ 
 ​ | Total     
 FairValue |   |       |   | ​ | ​ | GrossUnrealizedLosses |   |      |   | ​ 
 ​ |
|:-----------------------------------|:--|:--|:--------------------|:--|:--|:--|:--|:--|:----------------------|:--|:--|:--|:--|:--|:---------------------|:--|------:|:--|:--|:--|:----------------------|:--|-----:|:--|:--|:--|:----------|:--|------:|:--|:--|:--|:----------------------|:--|-----:|:--|:--|
| U.S. government agency obligations | ​ | ​ | ​                   | $ | — | ​ | ​ | ​ | ​                     | $ | — | ​ | ​ | ​ | ​                    | $ | 7,238 | ​ | ​ | ​ | ​                     | $ | -262 | ​ | ​ | ​ | ​         | $ | 7,238 | ​ | ​ | ​ | ​                     | $ | -262 | ​ | ​ |
| Corporate bonds                    | ​ | ​ | ​                   | ​ | — | ​ | ​ | ​ | ​                     | ​ | — | ​ | ​ | ​ | ​                    | ​ | 2,000 | ​ | ​ | ​ | ​                     | ​ |   -1 | ​ | ​